Fintel on MSN21h
JMP Securities Downgrades Syros Pharmaceuticals (SYRS)Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback